Serial Number
99154994
Owner
SpyGlass Pharma, Inc.Attorney
Hillary E. MaynardFirst Use Date
May 1, 2021
Filing Date
Apr 25, 2025
S Trademark
Serial Number: 99154994
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Hillary E. Maynard Polsinelli PC
PO Box 140310
Kansas City, MO 64114-0310
United States
Trademark Details
Filing Date
April 25, 2025
Registration Date
Not Registered
First Use Anywhere
May 1, 2021
First Use in Commerce
May 1, 2021
Published for Opposition
February 17, 2026
Goods & Services
Providing medical and scientific information and analysis in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; Providing medical and scientific research information in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof
Intraocular implants, namely, intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations; drug delivery devices sold empty for use in conjunction with intraocular lenses and lens stability rings, namely, an acrylic intraocular lens platform equipped for receiving pads; Intraocular implants being lenses; drug delivery devices sold empty for use in conjunction with intraocular implants, namely, an acrylic intraocular lens platform equipped for receiving pads
Scientific and technological services, namely, scientific research, analysis and design of products and technology in the fields of ophthalmic-related health conditions and short-term, intermittent and/or sustained intraocular drug delivery; Product development of technology for the treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions; Research and development services relating to technology for treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions
Implantable drug delivery devices with integrated pharmaceutical preparations for use in conjunction with intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations to treat eye conditions